Stephen Kevin Smith

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022.

QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland.

Part of Dassault Systèmes SA, Cambridge Combinatorial Ltd. is a company engaged in the design, production and supply of compounds for the pharmaceutical industry. The company is based in Cambridge, UK. Cambridge Combinatorial was acquired by Oxford Molecular Group Plc on October 15, 1998 for $20.78 million. The British company was founded by Allan P. Marchington.

Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom.

Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom.

Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom.

Part of Carolina Regent Corp., Laura Ashley, Inc. manufactures shirts, dresses, fragrances, and apparel products. The company is based in Fort Mill, SC.

Mellanox Technologies Belfast Ltd. supplies hardware engines for content and network processing. It offers regular expression processor for application awareness and security processing; and parallel string matcher for high performance network processing related search and lookup functions. The firm’s products are used in various applications, such as stateful packet classification, deep packet inspection, access control list execution, flow classification, TCP and IP header lookup and content and URL inspection and filtering. The company was founded in 2007 and is headquartered in Belfast, the United Kingdom.

Recycling Technologies Ltd. provides a machine and a service to recycle unsorted plastic waste. Its flagship machine, the RT7000, utilizes advanced thermal cracking technology. The firm’s solutions include End-of-Life Plastics and Plaxx. The company is headquartered in Swindon, the United Kingdom.

Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY.

Heimdall Protective Tech Ltd. develops innovative combination of shape and material to achieve both a cushioning and damping effect on impact. It offers shock absorbing technology and solutions. The company was founded by John Wood in 2013 and is headquartered in Newcastle Under Lyme, the United Kingdom.

EMV Capital Ltd (EMV Capital) is a private equity and venture capital subsidiary of NetScientific Plc founded in 2018 by Ilian Petkov Iliev. The firm is headquartered in London, United Kingdom.

Wroxall Abbey Estate Ltd. operates a hotel. The private company is based in Wroxall, UK. The CEO of the British company is Grant Howlett.

Liopa Ltd. provides biometric verification solutions for mobile. It offers LipRead VSR Platform, which helps to provide an accurate, easy-to-use and robust Visual Speech Recognition. The company was founded on November 26, 2015 and is headquartered in Belfast, the United Kingdom.

PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.